Future Health ESG (FHLT) Competitors

$12.00
0.00 (0.00%)
(As of 05/8/2024 ET)

FHLT vs. ARYD, PRE, CERO, TKNO, RLYB, DERM, JATT, DTIL, VNRX, and PSNL

Should you be buying Future Health ESG stock or one of its competitors? The main competitors of Future Health ESG include ARYA Sciences Acquisition Corp IV (ARYD), Prenetics Global (PRE), CERo Therapeutics (CERO), Alpha Teknova (TKNO), Rallybio (RLYB), Journey Medical (DERM), JATT Acquisition (JATT), Precision BioSciences (DTIL), VolitionRx (VNRX), and Personalis (PSNL). These companies are all part of the "medical" sector.

Future Health ESG vs.

Future Health ESG (NASDAQ:FHLT) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

24.6% of Future Health ESG shares are owned by institutional investors. Comparatively, 48.1% of ARYA Sciences Acquisition Corp IV shares are owned by institutional investors. 57.2% of Future Health ESG shares are owned by insiders. Comparatively, 53.5% of ARYA Sciences Acquisition Corp IV shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Future Health ESG's return on equity of -9.79% beat ARYA Sciences Acquisition Corp IV's return on equity.

Company Net Margins Return on Equity Return on Assets
Future Health ESGN/A -9.79% -0.28%
ARYA Sciences Acquisition Corp IV N/A -9.83%-5.41%

Future Health ESG and ARYA Sciences Acquisition Corp IV both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Future Health ESGN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/A

In the previous week, Future Health ESG's average media sentiment score of 0.00 equaled ARYA Sciences Acquisition Corp IV'saverage media sentiment score.

Company Overall Sentiment
Future Health ESG Neutral
ARYA Sciences Acquisition Corp IV Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Future Health ESGN/AN/A-$50KN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/A-$2.13MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Future Health ESG
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ARYA Sciences Acquisition Corp IV
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Future Health ESG has a beta of -0.12, indicating that its stock price is 112% less volatile than the S&P 500. Comparatively, ARYA Sciences Acquisition Corp IV has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500.

Summary

Future Health ESG beats ARYA Sciences Acquisition Corp IV on 4 of the 6 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FHLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FHLT vs. The Competition

MetricFuture Health ESGHolding Offices IndustryMedical SectorNASDAQ Exchange
Market Cap$71.23M$359.97M$5.00B$7.74B
Dividend YieldN/A7.61%2.84%3.96%
P/E RatioN/A5.55190.1419.48
Price / SalesN/A78.042,306.3081.09
Price / CashN/A64.0433.5428.61
Price / Book-7.6973.525.254.56
Net Income-$50,000.00$22.38M$105.29M$217.41M
7 Day PerformanceN/A0.69%0.21%0.96%
1 Month Performance-7.26%-1.03%-3.71%-2.71%
1 Year PerformanceN/A0.65%3.07%9.25%

Future Health ESG Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARYD
ARYA Sciences Acquisition Corp IV
0 of 5 stars
$11.33
flat
N/A+9.0%$85.43MN/A0.003
PRE
Prenetics Global
1.1865 of 5 stars
$5.05
+13.5%
$9.00
+78.2%
-59.4%$46.16M$21.74M-1.05400Gap Down
CERO
CERo Therapeutics
0 of 5 stars
$1.39
flat
N/AN/A$20.47MN/A0.008News Coverage
TKNO
Alpha Teknova
0.2127 of 5 stars
$1.78
+4.7%
N/A+0.0%$72.66M$36.68M-1.53210Upcoming Earnings
RLYB
Rallybio
2.2762 of 5 stars
$1.92
+3.8%
$12.20
+535.4%
-69.2%$72.60MN/A-1.0443Upcoming Earnings
Gap Up
DERM
Journey Medical
1.8307 of 5 stars
$3.69
+10.8%
$8.50
+130.4%
N/A$73.54M$79.18M-10.5441
JATT
JATT Acquisition
0 of 5 stars
$4.27
-8.0%
N/A-8.7%$73.66MN/A0.002,021High Trading Volume
DTIL
Precision BioSciences
4.0025 of 5 stars
$10.41
+5.8%
$60.00
+476.4%
-55.8%$72.00M$48.73M-0.65109Upcoming Earnings
VNRX
VolitionRx
1.3493 of 5 stars
$0.90
+4.7%
$2.50
+177.8%
N/A$73.86M$770,000.00-1.76110News Coverage
Gap Up
PSNL
Personalis
4.5738 of 5 stars
$1.47
+8.1%
$5.50
+274.1%
-31.1%$74.24M$73.48M-0.65223Analyst Forecast
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:FHLT) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners